Celularity
CELU | NASDAQ
$0.62
-$0.01 (-1.60%)
At close: Nov 16, 2026, 4:00 PM ET
$0.62
$0.00 (-0.15%)
After-hours:
Nov 16, 2026, 7:12 PM ET
-1.60%
(1D)No price chart data available for 1D timeframe.
Rating
23.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #957/1021 (Top 94%)
Key Statistics
Market Data
Market Cap $20.09M
1D Range
0.60 0.63
52W Range
0.60 2.10
Valuation (TTM)
PE -0.35
PB -0.57
EV/EBITDA -1.53
Valuation (NTM)
Forward PE 0.54
Forward PEG 0.01
Price Target $3.00
Cash Flow
FCF Yield -44.4%
SBC Adj. FCF Yield -81.2%
SBC Impact -82.7%
Margins
Gross Margin 19.2%
Operating Margin -264.3%
FCF Margin -47.8%
Growth (CAGR)
Revenue 3Y | 5Y 7.2% |
8.4%
Dil EPS 3Y | 5Y -10.7% |
-422.4%
FCF 3Y | 5Y 56.8% |
71.1%
Returns
ROA -47.7%
ROE 142.3%
ROIC -108.7%
Financial Health
Net Debt
$8.38M
Current Ratio 0.11
Interest Coverage -16.99
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering "off-the-shelf" allogeneic cell therapies, which are developed from placental sources. These innovative treatments ...
Sector Healthcare
Industry Biotechnology
Employees 115
IPO Date Aug 8, 2019
Website www.celularity.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove CELU